Delaying second COVID-19 vax can save lives: study
The BMJ research shows leaving the second dose of mRNA shots for 12 weeks reduces deaths from the disease under certain conditions
Delaying the second dose of the mRNA coronavirus vaccines in younger people may lead to fewer deaths, but only if certain conditions are met, a predictive modelling study suggests.
The findings add to the current pandemic debate over whether to extend the gap between vaccine doses to give as many people as possible some protection, or to stick with the dosing intervals designated in clinical trials.
For example, Pfizer has said there is no clinical evidence to support the UK's
